News
In the news
Talking cervical cancer awareness with U of M
January is National Cervical Cancer Awareness Month. The American Cancer Society estimates there were 140 new cases of cervical cancer in Minnesota in 2020.
Deanna Teoh with the University of Minnesota answers questions on the symptoms,…
U of M opens iPSC-derived CAR NK cell trial for patients with Non-Hodgkin Lymphoma as consolidation after an autologous transplant
MINNEAPOLIS, MN - The University of Minnesota is pioneering a novel therapeutic approach to improve the curative potential of hematopoietic stem cell transplantation for patients with Non-Hodgkin Lymphoma that are at high risk of relapse.…
A study out of the University of Minnesota is showing the killer instinct found in natural killer cells
Researchers at the Masonic Cancer Center, University of Minnesota have developed a system to produce and expand natural killer (NK) cells derived from human-induced pluripotent stem cells (iPSC). These manufactured NK cells were shown as…
U of M opens first-in-class engineered NK cell therapy trial for the treatment of patients with advanced multiple myeloma and leukemia
The University of Minnesota has become the first location in the world for a new innovative clinical trial for the treatment of acute myelogenous leukemia (AML) and multiple myeloma. The Phase 1 clinical trial for FT538 will eventually be…
Anne Blaes, MD, and Claudio Brunstein, MD, PhD, appointed to leadership positions at the Twin Cities’ only National Cancer Institute (NCI) designated comprehensive cancer center
Dr. Anne Blaes has accepted the role of co-leader of the Screening, Prevention, Etiology and Cancer Survivorship (SPECS) Research Program at the Masonic Cancer Center, University of Minnesota. Blaes is an Associate Professor of Medicine…
U of M opens a new clinical trial studying the effects of COVID-19 on cancer patients
The University of Minnesota, which is already at the forefront of COVID-19 research, has opened a new trial to study the short and long-term effects of the novel coronavirus on cancer patients. The study is a partnership between the…
Research breakthrough on specific form of cell death may overcome chemoresistance
Institute researchers find evidence in favor of necroptotic therapies
November 2, 2020 (Austin, Minn.) – Dr. Ilana Chefetz, head of the Cancer Stem Cells & Necroptosis lab at The Hormel Institute, published a review article focusing…
Breakthrough research using light-activated proteins for targeted therapy
Discoveries may impact future brain tumor therapy and treatment for hospital-acquired infections
October 27, 2020 (Austin, Minn.) – The Nucleotide Metabolism & Drug Discovery lab at The Hormel Institute, led by Dr. Jarrod French,…
Breakthrough research using light-activated proteins for targeted therapy
Discoveries may impact future brain tumor therapy and treatment for hospital-acquired infections
October 27, 2020 (Austin, Minn.) – The Nucleotide Metabolism & Drug Discovery lab at The Hormel Institute, led by Dr. Jarrod French,…